Press Releases April 21, 2026 11:00 AM

Northeast Bank Announces Dates for Fiscal 2026 Third Quarter Earnings Results and Conference Call

Northeast Bank Sets Date for Fiscal 2026 Q3 Earnings Release and Conference Call

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
NBN

Northeast Bank announced it will release its fiscal 2026 third quarter earnings on April 27, 2026, followed by a conference call on April 28, 2026. The call will be hosted by senior executives and available via live webcast and phone. Northeast Bank operates as a national lender and community bank, focusing on commercial real estate loans and small business financing.

Northeast Bank Announces Dates for Fiscal 2026 Third Quarter Earnings Results and Conference Call
NBN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Northeast Bank will announce Q3 fiscal 2026 earnings on April 27, 2026.
  • The bank specializes in commercial real estate lending and Small Business Administration-guaranteed loans.
  • Earnings conference call and webcast to be hosted by top executives providing investors insights.

PORTLAND, Maine, April 21, 2026 (GLOBE NEWSWIRE) -- Northeast Bank (the “Bank”) (NASDAQ: NBN), a Maine-based bank, announced today it will release its fiscal 2026 third quarter earnings results on Monday, April 27, 2026. Following the release, the Bank will host a conference call with a simultaneous webcast at 10:00 a.m. ET on Tuesday, April 28, 2026. The conference call will be hosted by Rick Wayne, President and Chief Executive Officer, Santino Delmolino, Chief Financial Officer, and Pat Dignan, Chief Operating Officer and Chief Credit Officer.

To access the conference call by phone, please go to this link (Phone Registration) you will be provided with dial in details. The call will be available via a live webcast, which can be viewed by accessing the Bank’s website at www.northeastbank.com and clicking on the Investor Relations section. To listen to the webcast, attendees are encouraged to visit the website at least 15 minutes prior to the start of the call to register, download and install any necessary audio software. Please note there is a slide presentation that will accompany the webcast. For those who cannot listen to the live broadcast, a replay will be available online for one year at www.northeastbank.com.

About Northeast Bank

Northeast Bank (NASDAQ: NBN) is headquartered in Portland, Maine and operates as both a national lender and a community bank. The Bank’s National Lending Division originates and purchases commercial real estate loans across the country. This Division specializes in complex credit structures and secondary market loan acquisitions, providing tailored financing solutions to a diverse national clientele. Complementing this segment, the Bank’s Small Business segment serves as a nationwide Small Business Administration Preferred Lender, offering government-guaranteed loans and small-balance insured financing. On a regional and national level, Northeast Bank provides a comprehensive suite of depository products and cash management and treasury services through a network of seven full-service branches in Maine alongside the Bank’s digital banking Division, ableBanking. Information regarding Northeast Bank can be found at www.northeastbank.com.

NBN-F

For More Information:
Santino Delmolino, Chief Financial Officer
Northeast Bank
27 Pearl Street, Portland, ME 04101
617.960.3634
www.northeastbank.com


Risks

  • Potential credit risk associated with commercial real estate and small business loan portfolios.
  • Uncertainties around economic conditions affecting loan performance and bank earnings.
  • Competitive pressures in the banking sector impacting growth and profitability.

More from Press Releases

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026